Lobbying client

ULTRAGENYX PHARMACEUTICAL INC.

Clinical-stage biotechnology company focused on debilitating metabolic genetic diseases.

The register keeps a separate record of this client for every firm that files for it and every spelling of its name. All 8 of its records are shown together here.

Filings
75
Filed by
8
Reported in-house
$2,290,000
Reported by firms
$2,229,000

These two are not added together. An organisation lobbying for itself reports its own spending, and the firms it retains report what they were paid; the rules ask the first to include the second, but filings do not always do so and a filing gives no way to tell. Each is shown as reported.

Reported lobbying by year

The larger of in-house and firm-reported each year, $ millions 2019 to 2026

Filings

75 filings, newest first.
Filing Filed by Amount
3rd Quarter - Termination
3rd Quarter 2026
FORBES-TATE $20,000 reported
3rd Quarter - Report
3rd Quarter 2026
MILLER STRATEGIES, LLC $90,000 reported
3rd Quarter - Report
3rd Quarter 2026
MEHLMAN CONSULTING, INC. $60,000 reported
3rd Quarter - Report
3rd Quarter 2026
ALPINE GROUP PARTNERS, LLC. $60,000 reported
3rd Quarter - Report
3rd Quarter 2026
ULTRAGENYX PHARMACEUTICAL INC. $280,000 reported
2nd Quarter - Report
2nd Quarter 2026
FORBES-TATE $30,000 reported
2nd Quarter - Report
2nd Quarter 2026
ULTRAGENYX PHARMACEUTICAL INC. $390,000 reported
1st Quarter - Report
1st Quarter 2026
ALPINE GROUP PARTNERS, LLC. $40,000 reported
2nd Quarter - Report
2nd Quarter 2026
ALPINE GROUP PARTNERS, LLC. $60,000 reported
2nd Quarter - Report
2nd Quarter 2026
MILLER STRATEGIES, LLC $140,000 reported

Filed by

Each firm that has reported for this client, and the client itself where it lobbies in-house, with the reports filed and the amounts they disclose.

Issues lobbied

How many report sections named each issue, counting the current version of each report.

Bills named in its filings

Bill numbers found in the filers' descriptions, most often named first.

BillCongressTimes named
H.R. 1262 119th 5
S. 932 119th 5
H.R. 1509 119th 3
S. 752 119th 3
S. 754 117th 3
H.R. 482 117th 3
H.R. 1730 117th 3
H.R. 1916 117th 3
S. 350 117th 3
S. 670 117th 3
H.R. 1 119th 2
H.R. 8646 119th 2
H.R. 9747 118th 2
H.R. 7384 118th 2
S. 4583 118th 2
H.R. 4502 117th 2
H.R. 3 116th 2
S. 2543 116th 2
H.R. 925 116th 2
H.R. 10545 118th 1
H.R. 5376 117th 1
H.R. 7567 117th 1
S. 250 117th 1
S. 3062 117th 1
S. 4010 116th 1

From reports filed under the Lobbying Disclosure Act. Firms report what each client paid them; an organisation lobbying for itself reports its own expenses. Amounts count the current version of each report once.